Table 3 Comparing the costs of treating subjects with colorectal pathology with or without screening from 60 to 69 years of age: considering a 2003 (early) and 2033 (late) cohort
From: Population screening for colorectal cancer: the implications of an ageing population
2003 (early cohort) | 2033 (late cohort) | |||
|---|---|---|---|---|
Non-screened | Screened | Non-screened | Screened | |
Early cohort | Early cohort | Late cohort | Late cohort | |
£ million (%) | £ million (%) | £ million (%) | £ million (%) | |
Screening | — | 100 (7) | — | 96.2 (7) |
Primary detection and treatment | 1208.2 (88) | 1174.0 (83) | 1247.2 (87) | 1203.8 (83) |
Surveillance | 95.2 (7) | 96.8 (7) | 100.9 (7) | 101.9 (7) |
Palliative care | 72.4 (5) | 46.4 (3) | 78.4 (5) | 50.4 (4) |
Total cost of colorectal cancer care | 1376 | 1417 | 1426 | 1452 |
